Mr. James Glenn Huffman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 503 N Main St, London, KY 40741 Phone: 606-877-1877 Fax: 606-878-9543 |
Mr. Mark David Huffman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 503 N Main St, London, KY 40741 Phone: 606-877-1877 Fax: 606-878-9543 |
Dr. Brennan P Greene, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1536 Story Ave, The Eye Care Institute Building, Louisville, KY 40206 Phone: 502-589-1500 Fax: 502-589-1556 |
Theodore M Wandzilak, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1348 Poplar Level Rd, Louisville, KY 40217 Phone: 502-634-8100 Fax: 502-637-6396 |
Donald Walter Bennett, OD MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1935 Bluegrass Ave, Suite 200, Louisville, KY 40215 Phone: 502-895-0040 Fax: 502-361-4488 |
Dr. Mark Cassol, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 Zorn Ave, Louisville, KY 40206 Phone: 502-287-4000 |
Lawrence Tenkman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1935 Bluegrass Ave, Suite 200, Louisville, KY 40215 Phone: 502-895-0040 Fax: 502-361-4488 |
Dr. Jacob Jones Yunker, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 100, Louisville, KY 40241 Phone: 502-897-9881 Fax: 502-897-9824 |
Christopher J Compton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 301 E Muhammad Ali Blvd, Louisville, KY 40202 Phone: 502-852-1665 |
Dr. Ashima Kumar Gupta, MD Ophthalmology - Pediatric Ophthalmology and Strabismus Specialist Medicare: Accepting Medicare Assignments Practice Location: 4940 Hazelwood Ave, Louisville, KY 40214 Phone: 502-368-3937 Fax: 502-368-0231 |
Dr. Norman D Radtke, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3 Audubon Plaza Dr, Suite 240, Louisville, KY 40217 Phone: 502-636-2823 Fax: 502-634-1646 |
Dr. George Nicholas Scarlatis, M.D., PH.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3336 Robin Rd, Louisville, KY 40213 Phone: 502-212-2594 |
Dr. Gabor G Nemeth, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4139 Cadillac Ct, Suite 200, Louisville, KY 40213 Phone: 502-473-4835 Fax: 502-473-4836 |
Dr. Henry J Kaplan, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 4121 Dutchmans Ln, Suite 410, Louisville, KY 40207 Phone: 502-897-9881 Fax: 502-897-9824 |
Dr. Rishi Verma Kumar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4940 Hazelwood Ave, Louisville, KY 40214 Phone: 502-368-3937 |
Dr. Amir Hadayer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 301 E Muhammad Ali Blvd, Kentucky Lions Eye Center, Louisville, KY 40202 Phone: 502-852-0710 |
Sushil V Kumar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4940 Hazelwood Ave, Louisville, KY 40214 Phone: 502-368-3937 Fax: 502-368-0231 |
Shorye Payne, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 301 E Muhammad Ali Blvd, Louisville, KY 40202 Phone: 502-852-5466 Fax: 502-852-4947 |
Dr. Melvin Douglas Gossman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2302 Hurstbourne Village Dr, 700, Louisville, KY 40299 Phone: 502-495-2122 Fax: 502-719-0146 |
Anne P Rowland, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9200 Leesgate Rd Ste 100, Louisville, KY 40222 Phone: 502-895-0040 Fax: 502-361-4488 |
News Archive
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
Researchers at Fred Hutchinson Cancer Research Center have developed biodegradable nanoparticles that can be used to genetically program immune cells to recognize and destroy cancer cells - while the immune cells are still inside the body.
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Microbiology of the oceans, gut microbes and STIs are just some of the topics reflecting modern microbial science that will be covered next week at the Society for General Microbiology's spring meeting 2010.
Cancer survivors who self-identified as being lesbian, gay or bisexual were more than twice as likely as heterosexual cancer survivors to have participated in cancer clinical trials, according to data from a small study presented at the Fifth AACR Conference on The Science of Cancer Health Disparities, held here Oct. 27-30, 2012.
› Verified 4 days ago